ERBB2 and aneurysmal bone cyst: To evaluate the systemic effects of CDK4/6 inhibitors on immune cells, we serially obtained peripheral blood from patients with HR-positive, HER2-negative ABC who were administered CDK4/6 inhibitors (N = 20; Additional file 1: Table S16).